Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Sava Technologies raises $36M in Series B funding led by Ascendia for biosensor manufacturing scale-up.
Amount Raised
$36 Million
Round Type
Series B
Greater LondonBiotechnologyHealth CareMedical DeviceHealth DiagnosticsInvestors
Description
Sava Technologies, a London-based health technology company, raised $36M in Series B funding led by Ascensia with participation from Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments, and Pentland Ventures. The raise brings the company's total funding to $68M. Sava develops a wearable biosensor platform using proprietary microsensor technology to continuously monitor biomarkers such as glucose in real time. The company plans to use the funds to accelerate manufacturing scale-up and commercial readiness.
Fundz sees it the moment Sava Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansSava Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.